Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
114 participants
INTERVENTIONAL
2020-06-01
2026-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Two Protocols of Shock Wave Therapy for Patients With Plantar Fasciitis
NCT06174142
Shock Wave Therapy for Sural Myofascial Pain Associated to Chronic Heel Pain
NCT04385329
Radial Extracorporeal Shock Wave Treatment for Chronic Plantar Fasciopathy
NCT02679521
Efficacy of the Treatment of Plantar Orthoses With Extracorporeal Shock Wave Therapy in Plantar Fasciitis
NCT04461197
Plantar Fasciopathy and the Effectiveness of Radial Extracorporeal Shockwave Therapy, Physical Training or Usual Care
NCT03472989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Randomized controlled trials have compared focused and radial shockwave therapy to placebo and other conservative measures in the treatment of chronic plantar fasciitis and overall demonstrated benefit. Only one study has directly compared radial and focused shockwave therapy in this population, although pain was not an outcome of focus in the study. The current study aims to collect patient-reported outcomes on both pain and function following radial vs. focused shockwave therapy vs. control therapy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Patients in the control group will be treated using the home therapy protocol only.
Home therapy
Stretching and ice massage
Radial shockwave therapy
Patients will receive 4 sessions of radial shockwave therapy.
Radial shockwave therapy
Target intensity will be within a range of 3.5-5.0 bar at maximum Hz, titrated up to patient tolerance within 100 pulses. Total of 3000 pulses.
Shockwave therapy device
The shockwave therapy device will be used to administer either radial or focused shockwave therapy.
Home therapy
Stretching and ice massage
Focused shockwave therapy
Patients will receive 4 sessions of focused shockwave therapy.
Focused shockwave therapy
Target intensity will be within a range of 0.15-0.25 mJ/mm2 at maximum Hz, titrated up to patient tolerance within 100 pulses. Total of 3000 pulses.
Shockwave therapy device
The shockwave therapy device will be used to administer either radial or focused shockwave therapy.
Home therapy
Stretching and ice massage
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Radial shockwave therapy
Target intensity will be within a range of 3.5-5.0 bar at maximum Hz, titrated up to patient tolerance within 100 pulses. Total of 3000 pulses.
Focused shockwave therapy
Target intensity will be within a range of 0.15-0.25 mJ/mm2 at maximum Hz, titrated up to patient tolerance within 100 pulses. Total of 3000 pulses.
Shockwave therapy device
The shockwave therapy device will be used to administer either radial or focused shockwave therapy.
Home therapy
Stretching and ice massage
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Minimum VAS pain of 40/100 (4/10; morning pain when taking first steps, pain after prolonged walking/standing)
* English-speaking
Exclusion Criteria
* Platelet-rich plasma injection within the past 6 months
* History of previous foot surgery
* Bilateral heel pain
* Coagulopathies or use of anti-coagulants
* Local and systemic neurologic or vascular insufficiencies
* Rheumatologic disorders
* Systemic inflammatory disorders
* Active or chronic infection in the area
* Lower extremity bone disorders (e.g., Paget's disease, osteomyelitis)
* Calcaneal fractures
* Nerve entrapment
* Ruptures in tendon
* Non-English speaking
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital for Special Surgery, New York
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kristina Quirolgico, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital for Special Surgery, New York
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital for Special Surgery
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-1517
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.